Psyence Biomedical Ltd. Common Shares Long-term Investment Intensity

Latest as of September 2025: 40.4%

Psyence Biomedical Ltd. Common Shares long-term investment intensity. Psyence Biomedical Ltd. Common Shares (PBM) has a Long-term Investment Intensity of 40.4% as of September 2025. Long-term investments of $5.17 Million represent 40.4% of total assets of $12.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of Psyence Biomedical Ltd. Common Shares for a breakdown of total debt and financial obligations.

LT Investment Intensity

40.4%
LT Investments / Total Assets

Long-term Investments

$5.17 Million
USD

Total Assets

$12.81 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Psyence Biomedical Ltd. Common Shares (2025–2025)

Long-term investment intensity of Psyence Biomedical Ltd. Common Shares from 2025 to 2025. This chart shows how Psyence Biomedical Ltd. Common Shares's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of September 2025, the intensity stands at 40.4%, reflecting long-term investments of $5.17 Million against total assets of $12.81 Million USD.

Psyence Biomedical Ltd. Common Shares Long-term Investment Intensity by Year (2025–2025)

Psyence Biomedical Ltd. Common Shares long-term investment intensity by year from 2025 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Psyence Biomedical Ltd. Common Shares from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Psyence Biomedical Ltd. Common Shares balance sheet assets.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 10.2% $745.00K $7.32 Million —
pp = percentage points